SHARE Presentation: Palliative Care for Womenbkling
Dr. Michael Pearl discusses supportive palliative care for women with cancer, how it differs from hospice care, and the New York Palliative Care Information Act. Dr. Michael Pearl is Professor and Director of the Division of Gynecologic Oncology in the Department of Obstetrics, Gynecology and Reproductive Medicine at Stony Brook University Hospital.
Dr. Paul Sabbatini: Recurrent Ovarian Cancer: Now What? (SHARE Program)bkling
On May 22, 2013, SHARE presented "Recurrent Ovarian Cancer: Now What?" The program featured Dr. Ginger Gardner and Dr. Paul Sabbatini of Memorial Sloan-Kettering Cancer Center discussing treatment strategies, as well as new approaches and agents, for managing an ovarian cancer recurrence. Listen to the audio here http://www.sharecancersupport.org/sabbatini.
The information in this presentation is not intended to be a substitute for professional medical advice, diagnosis or treatment.
Understanding The Principles Multi-Disciplinary Approach To Cancer Treatment ...flasco_org
Providing a course that is relevant, practical and patient-centered that will positively impact the speed in which entry-level oncology specialists integrate into the oncology practice setting.
SHARE Presentation: Palliative Care for Womenbkling
Dr. Michael Pearl discusses supportive palliative care for women with cancer, how it differs from hospice care, and the New York Palliative Care Information Act. Dr. Michael Pearl is Professor and Director of the Division of Gynecologic Oncology in the Department of Obstetrics, Gynecology and Reproductive Medicine at Stony Brook University Hospital.
Dr. Paul Sabbatini: Recurrent Ovarian Cancer: Now What? (SHARE Program)bkling
On May 22, 2013, SHARE presented "Recurrent Ovarian Cancer: Now What?" The program featured Dr. Ginger Gardner and Dr. Paul Sabbatini of Memorial Sloan-Kettering Cancer Center discussing treatment strategies, as well as new approaches and agents, for managing an ovarian cancer recurrence. Listen to the audio here http://www.sharecancersupport.org/sabbatini.
The information in this presentation is not intended to be a substitute for professional medical advice, diagnosis or treatment.
Understanding The Principles Multi-Disciplinary Approach To Cancer Treatment ...flasco_org
Providing a course that is relevant, practical and patient-centered that will positively impact the speed in which entry-level oncology specialists integrate into the oncology practice setting.
Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface MalignanciesMary Ondinee Manalo Igot
The prognosis of most peritoneal surface malignancies were previously dismal. However, with the incorporation of HIPEC to standard of care, we have been seeing doubling of survival for select malignancies. Appropriate patient selection is crucial.
Neoadjuvant Chemoradiation in Borderline resectable pancreatic adenocarcinomaDr.Bhavin Vadodariya
Comprehensive review of evidence in Neoadjuvant Chemoradiation in Borderline resectable pancreatic adenocarcinoma which includes classification of pancreatic cancer.
Field of oncology has evolved since many decades! This presentation will demonstrate how oncology had evolved. Special focus is on current radiation oncology and surgical oncology practices along with principles of oncology.
Dr. Aimee Thompson discusses the impact of childhood cancer on the family. To listen the audio recording, please visit: http://www.alexslemonade.org/campaign/symposium-childhood-cancer
Has cancer science got you stumped and overwhelmed? Leading gynecologic oncologist, Dr. Don Dizon, takes us to cancer college in this webinar. He explains the science behind ovarian cancer, how it develops, how it's diagnosed, and how ovarian cancer treatments work.
Following diagnosis and treatment for breast cancer, many women experience changes in their sexuality. In this webinar, Madeleine M. Castellanos, MD, a psychiatrist specializing in sex therapy and sexual medicine, addresses the physical, psychological, and relationship issues that often emerge and explores strategies to find happiness and fulfillment.
Hospice care and palliative care: Is there a difference between the two, and if so, what?
Many people still think that palliative care means hospice care. But today, hospice is only a small part of palliative care.
The goal of palliative care is to prevent or treat the symptoms and side effects of a disease; and it should be part of the picture from the first day a serious illness is diagnosed.
Dr. Jim Meadows, Director of Hospice and Palliative Care at Tennessee Oncology, will discuss this important topic. How does a family and a health care team best work together to guide a patient through a terminal illness? How does everyone continue to support quality, patient-centered, end-of-life care?
I didn't know this option of Palliative care existed prior to my mother's passing earlier this year of colorectal cancer. However, I do now know about it and want to share it with all of you
Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface MalignanciesMary Ondinee Manalo Igot
The prognosis of most peritoneal surface malignancies were previously dismal. However, with the incorporation of HIPEC to standard of care, we have been seeing doubling of survival for select malignancies. Appropriate patient selection is crucial.
Neoadjuvant Chemoradiation in Borderline resectable pancreatic adenocarcinomaDr.Bhavin Vadodariya
Comprehensive review of evidence in Neoadjuvant Chemoradiation in Borderline resectable pancreatic adenocarcinoma which includes classification of pancreatic cancer.
Field of oncology has evolved since many decades! This presentation will demonstrate how oncology had evolved. Special focus is on current radiation oncology and surgical oncology practices along with principles of oncology.
Dr. Aimee Thompson discusses the impact of childhood cancer on the family. To listen the audio recording, please visit: http://www.alexslemonade.org/campaign/symposium-childhood-cancer
Has cancer science got you stumped and overwhelmed? Leading gynecologic oncologist, Dr. Don Dizon, takes us to cancer college in this webinar. He explains the science behind ovarian cancer, how it develops, how it's diagnosed, and how ovarian cancer treatments work.
Following diagnosis and treatment for breast cancer, many women experience changes in their sexuality. In this webinar, Madeleine M. Castellanos, MD, a psychiatrist specializing in sex therapy and sexual medicine, addresses the physical, psychological, and relationship issues that often emerge and explores strategies to find happiness and fulfillment.
Hospice care and palliative care: Is there a difference between the two, and if so, what?
Many people still think that palliative care means hospice care. But today, hospice is only a small part of palliative care.
The goal of palliative care is to prevent or treat the symptoms and side effects of a disease; and it should be part of the picture from the first day a serious illness is diagnosed.
Dr. Jim Meadows, Director of Hospice and Palliative Care at Tennessee Oncology, will discuss this important topic. How does a family and a health care team best work together to guide a patient through a terminal illness? How does everyone continue to support quality, patient-centered, end-of-life care?
I didn't know this option of Palliative care existed prior to my mother's passing earlier this year of colorectal cancer. However, I do now know about it and want to share it with all of you
Basics of palliative care including symptom management: pain, dyspnea, nausea and constipation; family meetings, goals-of-care, end-of-life care, and artificial nutrition.
In this webinar, Dr. Popp will discuss everything you need to know about palliative care! This is an important webinar for colorectal cancer patients and their loved ones.
We will cover the topic of Palliative Care – specialized medical care for people with serious illnesses. It focuses on providing patients with relief from the symptoms and stress of a serious illness. The goal is to improve quality of life for both the patient and the family.
Presented by Dr. Jean S. Kutner, MD, MSPH a tenured Professor of Medicine in the Divisions of General Internal Medicine (GIM), Geriatric Medicine, and Health Care Policy and Research at the University of Colorado School of Medicine (UC SOM)
Cancer Survivorship Care: Global Perspectives and Opportunities for Nurse-Le...Carevive
The 18th CNSA Annual Winter Congress, held Perth, Australia will featured On Q Health’s co-founder Dr. Carrie Stricker as a keynote speaker. The theme for this year’s edition is “Cancer Nursing: Expanding the Possibilities” and will focus on exploring the opportunities that exist in cancer nursing in 2015 and beyond.
By Nancy Hutchison, MD. The role of cancer rehabilitation in adding value to oncology care and its contribution to achieving the Triple Aim of health care.
Presentation on palliative care given at the Caregiver's Conference for the Cystic Fibrosis Affiliate and Satellite Sites at Riley Children's Hospital.
Can we solve the adult primary care shortage without more physicians? CHC Connecticut
Tom Bodenheimer,of the Center for Excellence in Primary Care at UCSF Dep’t of Family and Community Medicine talks about addressing the primary care shortage at the 2014 Weitzman Symposium
A brief introduction to what Keele's Stratified care for low back pain: Subgrouping and targeting treatment for low back pain in primary care (STarT Back).
The STarT Back approach uses a simple tool to match patients suggesting with back pain to treatment packages appropriate for them. This has been shown to decrease disability from back pain, reduce time off work, and save money by making better use of health resources.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...bkling
Making treatment decisions is stressful. The work of understanding complex medical information, crafting questions for your medical team, and trusting oneself is hard. We break down this intense time in ways that might feel more manageable and help you regain a sense of calm as you work hard to care for yourself at each turn in the road. Let’s talk about it.
Report Back from SGO: What’s the Latest in Ovarian Cancer?bkling
Are you curious about what’s new in ovarian cancer research or unsure what the findings mean? Join Dr. Elena Pereira, a gynecologic oncologist at Lenox Hill Hospital, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Pereira will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Part I - Anticipatory Grief: Experiencing grief before the loss has happenedbkling
Anticipatory grief is the emotional experience when there is an impending loss that will occur. Often, people associate loss and grief with death, this is just one area in which grief and loss can occur. Anticipatory grief is often a slower grieving process marked by intermittent, small or large losses. In the world of cancer, anticipatory grief may show up in a variety of ways, such as before a major surgery, losing hair from chemotherapy treatment or caring for a loved one with advanced cancer.
Learn about anticipatory grief and ways to cope with it. We will also explore methods to heal from this challenging experience.
See it and Catch it! Recognizing the Thought Traps that Negatively Impact How...bkling
A cancer diagnosis is stressful. Feelings of worry, fear, self-doubt, sadness, and loneliness are normal but can feel exhausting and consuming at times. Cultivating a habit of thought-watching and learning to recognize thought traps that might be contributing to our discomfort can help us respond and care for ourselves in helpful ways. Learn more about the connection between what we think and how we feel and what you can do about it that might impact how you feel today. Let’s talk about it.
Advocating for Better Outcomes: Ovarian Cancer and Youbkling
Many parts of your life can affect your health and your cancer risk. Things like your race, ethnicity, where you live, and your finances matter. Even so, how can you get the health care you need and lower your cancer risk? What should you and your family do if you need to speak up?
Join this special talk about knowing your risk, ovarian cancer care, and ways we can speak up to improve our health. provided by two experts from Memorial Sloan Kettering Cancer Center (MSK) and SHARE.
Do you want to feel empowered and confident in preserving your independence and lowering your risk for injury? Learn how to reduce the risk of injury, how to fall safely, and maximize quality of life. Avoid common pitfalls and connect with others who share this concern!
Speakers: Ayden Jones, Falls Prevention Consultant and A Matter of Balance Master Trainer, and Janvier Hoist-Forrester, OTS.
Embracing Life's Balancing Act: Part 2 - Fall Action Planbkling
Do you want to feel empowered and confident in preserving your independence and lowering your risk for injury? Learn how to reduce the risk of injury, how to fall safely, and maximize quality of life. Avoid common pitfalls and connect with others who share this concern!
Speakers: Ayden Jones, Falls Prevention Consultant and A Matter of Balance Master Trainer, and Janvier Hoist-Forrester, OTS.
Let's Talk About It: Communication, Intimacy, and Sex… Oh My!bkling
Changes to your body are normal to experience related to a cancer diagnosis. But the grief and the learning to live with a changed body take time. But what if you share your body with someone else? What if finding pleasure and connection through intimacy feels like an overwhelming or insurmountable obstacle on your road to healing? Let's talk together about our personal experiences and questions surrounding this important topic of communication and intimacy.
Let's Talk About It: To Disclose or Not to Disclose?bkling
Sharing your cancer diagnosis with others can bring up a range of unexpected feelings and questions. Deciding who you tell, how much to share, and why are all important things to consider. The answer to these questions is personal and it varies not only between survivors but also in different settings and relationships in your life. We talk together about personal experiences and questions surrounding this important topic.
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
Dr. Ebony Hoskins, gynecologic oncologist at MedStar Washington Hospital Center, provides a comprehensive update from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer. Dr. Hoskins breaks down the research presented at the conference, discusses new developments, and addresses the most pressing questions.
Learn Tips for Managing Chemobrain or Mental Fogginessbkling
Chemobrain, or mental fogginess, is experienced by many patients during and after cancer treatment. But what are some strategies that help?Dennis Lin, OTD, OTR/L, Occupational Therapist at City of Hope National Medical Center, will provide tips on how you can manage chemobrain and support better engagement in your daily life.
Vaccines: Will they become a form of Secondary and Primary Breast Cancer Prev...bkling
Our guest speaker Lee Gravatt Wilke, MD, Senior Medical Director at the University of Wisconsin School of Medicine and Public Health, explains the current state of vaccine clinical trials in breast cancer followed by a review of the STEMVAC trial, design of the vaccine, and the current state of the accrual and next steps.
Let's Talk About It: Uterine Cancer (Advance Care Planning)bkling
Although it can be a difficult topic, advance care planning is very important for anyone facing a cancer diagnosis. The goal of advance care planning is to set up a plan to make sure you get the care you want in the future. It is critical to prepare for future decisions about your medical care with your family and support system. We discuss how to start and continue those important conversations. Learn about the differences between palliative care and hospice, when to bring up your wishes with your medical team, and how to prepare your family for navigating these decisions.
Moving Forward After Uterine Cancer Treatment: Surveillance Strategies, Testi...bkling
You’ve been treated for uterine cancer. Now what? With surveillance strategies varying from doctor to doctor, it can be hard to know which advice you should follow. Dr. Jennifer Mueller, Head of the Endometrial Cancer Section, Gynecologic Oncology Service at Memorial Sloan Kettering Cancer Center, delves into surveillance guidelines, which tests to consider, and how to keep an eye out for any symptoms which could indicate recurrence.
Understanding and Managing Chemo-Induced Peripheral Neuropathy (CIPN)bkling
Certain chemotherapy drugs can cause chemotherapy-induced peripheral neuropathy (CIPN), which is one of the most common side effects of treatment. Chemotherapy treatments cause peripheral neuropathy by damaging the nerves in the fingers, hands, arms, legs, and feet. This can lead to symptoms including pain, numbness, tingling, and difficulty with mobility, which can greatly impact one’s quality of life. Dr. Anasheh Halabi is an Assistant Clinical Professor in Neuromuscular Medicine at UCLA who specializes in neuropathies and is a leading specialist in caring for patients with neurotoxicities related to cancer drugs. She discusses chemotherapy-related neuropathies, expectations, and management. The perspective of a patient who has experienced CIPN will also be included in the program.
Let's Talk About It: Sick and Tired of Being Sick and Tiredbkling
Cancer-related fatigue is one of the most challenging treatment-related side effects. Your level of cancer-related fatigue may vary from day to day or last for extended periods. Survivors experience fatigue related to cancer treatment, but fatigue can also be a side effect of the logistical, mental, and emotional toll cancer takes on someone. This mental and emotional fatigue can often be minimized and particularly challenging to cope with as a survivor. Learn how to address your fatigue in mindful ways so you can navigate the days ahead.
What’s New with PARP Inhibitors and Ovarian Cancer?bkling
PARP inhibitors have revolutionized ovarian cancer treatment, but recent updates to the FDA-approved indications have caused confusion and raised questions for patients. So what do these changes mean? Dr. Thomas Herzog, Deputy Director of the University of Cincinnati Cancer Center, discusses the current landscape of PARP inhibitors for ovarian cancer and what it means for you.
Caring for You: The Mental & Emotional Toll of Survivorshipbkling
A cancer diagnosis is stressful. From gathering information about treatment options to navigating relationships with loved ones, it is normal to feel overwhelmed and emotional. This session will provide concrete tools for sharpening self-awareness to better understand needs and gain strategies for coping with intense emotions like worry and fear.
Let's Talk About It: Ovarian Cancer (Shifting Focus: The Relationship with Yo...bkling
Cancer treatment can change the relationship you have with your body. Surgical scars, hair loss, changes in sensitivity, discomfort or pain, and ongoing side effects can be overwhelming and emotional to experience. Feelings of loss, disconnect, anger, and shame are normal to have but can be uncomfortable or complicated to navigate. Join us on Wednesday, February 14th as together we openly discuss the path forward to healing and reclaiming the important relationship with your body post-diagnosis.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Less Pain, More Gain: Palliative Care for Ovarian Cancer
1. Less Pain, More Gain:
Palliative Care Strategies for
Recurrent Ovarian Cancer
Carolyn Lefkowits, M.D. M.P.H. M.S.
Assistant Professor, Gynecologic Oncology & Palliative Care
University of Colorado Denver
SHARE Webinar Sept 27, 2017
2. Objectives
• Define palliative care & differentiate it from
hospice
• List at least 3 evidence-based benefits of
palliative care
• Differentiate between primary & specialty
palliative care
• Leave with homework
3. Outline: Palliative Care
• What is it?
• Why do we need it?
• How can you get it?
• Barriers
• Next steps
4. What is Palliative Care?
Palliative Care (PC): “therapies that address the
multiple issues that cause suffering for patients and
their families and impact their quality of life”
NOT synonymous with end-of-life care/hospice
Can be offered concurrently with curative therapy
Smith et al JCO 2012
5. What is Palliative Care?
“Palliative care is specialized medical care for
people living with serious illness. It focuses on
providing relief from the symptoms and stress of a
serious illness. The goal is to improve quality of life
for both the patient and the family…It is appropriate
at any stage in a serious illness and can be provided
along with curative treatment.”
“an extra layer of support”
Center to Advance Palliative Care
8. ASCO & AAHPM
Domains of Palliative Care
1. Symptom assessment &
management
2. Psychosocial assessment
& management
3. Spiritual & cultural
assessment &
management
4. Communication & shared
decision making
5. Advance care planning
6. Coordination/continuity of
care
7. Appropriate specialty
palliative care & hospice
referral
8. Carer support
9. End-of-life care
ASCO Palliative Care in Oncology Symposium, 2015
9. Outline: Palliative Care
• What is it?
• Why do we need it?
• Barriers
• How can you get it?
• Next steps
10. Why do we need palliative care?
You are a Bridge: Palliative Care
1 min 40 sec youtube video
(https://youtu.be/lDHhg76tMHc)
11. Benefits of palliative care
Nonrandomized studies have shown the following
benefits without decreased survival
• Reduced pain & other distress
• Improved health-related QOL
• High patient & family satisfaction with care
• Increased likelihood of location of death being
outside of hospital
• Reduction in hospital & ICU length of stay
Meier et al 2006
12. • Randomized trial: 151 stage IV lung cancer patients
– Arm 1: standard care
– Arm 2: palliative care integrated from the time of diagnosis
• Palliative care group
– Improved quality of life
– Less depression
– Less aggressive care at the end-of-life
– Statistically significantly longer survival
13. “It is the panel’s expert consensus that
combined standard oncology care and palliative
care should be considered early in the course
of illness for any patient with metastatic
cancer and/or high symptom burden”
14. • n=87 patients discontinuing anti-cancer therapy
• Integrated Care Model (ICM) patients had seen PC prior to
decision to d/c anti-cancer therapy
• ICM patients
– Better QOL
– Less depression
– Less chemo within last 6 wks of life (40% vs 6%, p=0.001)
– Improved median survival (HR 0.48, p=0.46)
15. • n=95 patients with gyn malignancy & inpatient PC consultation for
symptom management
• Improvement in prevalence moderate to severe symptom
intensity
– between PC consult & discharge for: pain, anorexia, fatigue & nausea
(magnitude 58-66%)
– within one day of PC consult for: pain, fatigue, nausea (magnitude 50-55%)
• Majority of improvement that occurred between consult &
discharge happened within 24hrs of consult
16. • Model of routine care vs routine care + PC referral at
time of diagnosis of recurrent platinum-resistant disease
• Data from Temel et al informed creation of model
• Early palliative care associated with
– Cost savings $1285 per patient over routine care
– ICER <$50,000/QALY
– Assuming no clinical benefit other than QOL improvement,
remained highly cost-effective
18. Palliative Care & Ovarian Cancer:
Christine’s Story
https://soundcloud.com/get-palliative-care/a-quality-life-episode-1-christines-story
19. Outline: Palliative Care
• What is it?
• Why do we need it?
• How can you get it?
• Barriers
• Next steps
20. Where can you get palliative care?
• Primary palliative care: delivered by non-
palliative care specialists
• Specialty palliative care: delivered by palliative
care specialists
– In the hospital
– In an outpatient clinic
– At home
• Home palliative care
• Hospice care
21. What actually happens at a palliative care
appointment?
• n=67 patients with advanced lung cancer
• 1st
palliative care visit median 55 minutes
(range 20-120 min)
• Mean minutes spent (range)
– Symptom management 20 mins (0-75)
– Patient & family coping 15 mins (0-78)
– Illness understanding & education 10 mins (0-35)
Jacobsen et al JPM 2011
22. Center to Advance Palliative Care
(getpalliativecare.org)
• Quiz – “is palliative care right for you?”
• Searchable provider directory
23. Outline: Palliative Care
• What is it?
• Why do we need it?
• How can you get it?
• Barriers
• Next steps
24. Barriers to Palliative
Care Integration
• Limited availability
• Poor reimbursement
• Lack of provider education
• Palliative care has a branding problem
25. Barriers: Lack of Provider Education
• Survey 327 practicing gyn oncologists
– Only 45% said training helped them relate to
terminally ill patients & families
• Survey 103 gyn oncology fellows
– Quality & quantity of palliative care training
rated lower than other common oncologic topics
• Survey 29 gyn onc fellowship directors
– 14% written pall care curriculum
– 48% elective/required pall care rotation
Ramondetta et al 2004
Lesnock et al 2013
Lefkowits et al 2015
27. Palliative Care Has a Branding Problem
“How knowledgeable, if at all, are you about palliative care?”
CAPC 2011
28. Branding Problem: Providers
• Lack knowledge of specialty palliative care
services & their benefits
• Equate palliative care with end-of-life care
• Patients unlikely to request palliative care
referral, but open to it when recommended by
oncologist
CAPC 2011
Schenker et al JOP 2014
Schenker et al JPM 2014
29. Palliative Care Has a Branding Problem
“One of the greatest remaining challenges is the
need for better understanding of the role of
palliative care among both the public and
professionals across the continuum of care so that
hospice and palliative care can achieve their full
potential for patients and their families”
Institute of Medicine (IOM)
Dying in America 2014
30. Palliative Care Has a Branding Problem
Age 25+ Age 65+
Very likely 63% 62%
Somewhat likely 29% 28%
Not too/Not at all likely 6% 6%
“How likely, if at all, would you be to consider palliative
care for a loved one if they had a serious illness?”
31. Outline: Palliative Care
• What is it?
• Why do we need it?
• How can you get it?
• Barriers
• Next steps
32. Next Steps to Improve Palliative Care
Integration for Women with Ovarian
Cancer
• Education
• Research
• Policy
33. Objectives
• Define palliative care & differentiate it from
hospice
• List at least 3 evidence-based benefits of
palliative care
• Differentiate between primary & specialty
palliative care
• Leave with homework – familiarize yourself with
palliative care resources near you
(getpalliativecare.org)
34. Take Home Points
• What is palliative care
– “an extra layer of support”
• Why palliative care
– Because it improves clinical outcomes without
adversely affecting survival
• How palliative care
– Getpalliativecare.org
• When palliative care
– Why not now?
So delighted to be here today speaking to you about a topic that’s close to my heart.
My name is Carolyn Lefkowits, I’m a gynecologic oncologist & palliative care physician at the University of Colorado Denver and I am fellowship trained in both disciplines. In my clinical work at the University of Colorado I do primarily gyn oncology and then ½ day per week I have a palliative care clinic at the cancer center where I see patients with all kinds of cancers.
My objectives are that by the end of this session, you would be able to
-define palliative care & differentiate it from hospice or EOL care
-list at least 3 evidence-based benefits of palliative care for people with cancer
-differentiate between primary and specialty palliative care
-and I’d like you to leave with homework – that homework will be to familiarize yourself with the palliative care resources available to you wherever you are
We’ll start by talking about what pall care is (and isn’t)
Then I’m going to review some of the evidence supporting integration of palliative care into cancer care, or why we need it
Palliative care can be delivered in lots of different ways, so we’ll talk about some of the ways you can get it
We’ll go over some barriers to palliative care integration
And then next steps toward improved integration of palliative care into the care of women with ovarian cancer
What is palliative care? You may read lots of different definitions out there. The definition on this slide is from the American Society of Clinical Oncology…Palliative care includes therapies that address the multiple issues that cause suffering for patients and their families and impact their quality of life.
Just to dispel up front a common misconception, PC is NOT synonymous with EOL care, can be offered concurrently with surgery, chemotherapy or radiation therapy, including when the goal of that therapy is cure.
Here’s another definition that I like, this one is from the Center to Advance Palliative Care, I’m going to read it to you…
In short, palliative care serves as “an extra layer of support” for women and their families who are living with ovarian cancer
This phrase “extra layer of support” is one that comes from a public opinion survey done by the CAPC, where they found that the majority of people did not know what palliative care was, we’ll talk more about that later, but once it was explained to them, more at length, this short phrase resonated with people and I use it all the time with patients & colleagues
So objective #1 was that you’d be able to define palliative care, I think the easiest definition to remember is “an extra layer of support”
When talking about palliative care, I think it’s important to spend most of our time talking about what it is, as opposed to what it isn’t. But I want to make sure to drive home that point that palliative care is not synonymous with hospice care. Hospice care falls under the umbrella of palliative care. Hospice care, unlike palliative care, is only available to patients with a limited prognosis who are no longer pursuing disease-directed therapy, like chemo or surgery. Palliative care, on the other hand, is not limited in that way.
So all hospice care can be considered palliative care, but hospice care represents only a small subset of palliative care
This is a nice pictorial representation of an integrated model of palliative care, where palliative care is integrated into cancer care from the time of diagnosis. In reality, I don’t think the need for palliative care is necessarily a straight line increase over time, I think that line can go up and down over the disease course depending on need, but the point being that palliative care is a part of the equation from the beginning, as is advance care planning. And then for patients who ultimately die of their disease, hospice care near the end of life and bereavement care for surviving family after death are part of the spectrum of care and those elements, hospice care & bereavement care, also falls under the umbrella of palliative care.
To get a bit more concrete about what palliative care is, what clinical services it provides, this slide contains the nine domains of palliative care as outlined by the American Society of Clinical Oncology, ASCO, and the American Association of Hospice & Palliative Medicine, AAHPM
Palliative care includes…
Communication & shared decision making Those conversations may include prognosis or advance care planning, or just decision-making at branch points in care when we’re choosing between multiple options, figuring out how we best match that patients values and goals to her treatment.
Advance care planning: detailed discussion of ACP, benefits, barriers, is beyond what we have time for today, but it’s critically important, in the setting of a serious illness such as ovarian cancer that their loved ones and medical team have a sense of what that person would want for their care if they were suddenly to get sicker or be unable to speak for themselves
Number 6 is coordination/continuity of care: this can be helping to coordinate a clear message for patients who have multiple services involved in their care. Also includes helping patients navigate the healthcare system. For example, helping match services available in the system to patient’s goals and values.
Number 7 is appropriate palliative care & hospice referral – here palliative care referral refers to palliative care specialists, and, as we’ll discuss more later, not all palliative care can or should be delivered by palliative care specialists
Number 8 is carer, or caregiver support
Number 9 is EOL care
So before we go on to why we need palliative care, just to review, palliative care services as an extra layer of support to patients and families facing serious illness. It can be offered concurrently with disease-directed therapy with the goal of improving quality of life. This distinguishes it from hospice care, which is available only to patients with limited prognosis who are no longer pursuing disease-directed therapy. Palliative care includes, among other things, symptom management, assistance with patient & family coping and efforts to improve illness understanding.
Why do we need palliative care? In summary, because high quality evidence shows multiple benefits, to both individual patients & families, and the healthcare system, providing truly high value care. Now I want to review some of the evidence behind that assertion.
I had a couple of videos that I wanted to show with this presentation, but from an AV standpoint we couldn’t get those to work for the webinar, but links to them will be available in the version of my slides that will be available online
Let’s talk about the benefits of palliative care
At this point there have been multiple retrospective studies showing benefits of palliative care with respect to quality of life, for both patients and caergivers, including
-reduced pain & other distress
-improved HRQOL
-high patient & family satisfaction with care
For patients who ultimately die of their illness, patients who have had involvement with palliative care specialists are less likely to die in the hospital, more likely to die at home or in another location that they prefer
And palliative care is association with reduction in hospital & ICU LOS
The question of how, if at all, palliative care impacts survival is a pretty hot topic. At the very least, all comparative trials that involve palliative care interventions have shown no decrement in survival. We are not shortening peoples lives by integrating palliative care into their care (I mention this because it’s a common fear, I think among both patients & providers, what if the palliative care providers just try to talk everyone into hospice? But that’s not how it works, and the data bears out that palliative care does NOT shorten survival)
I’d like to tell you a bit about the most famous study of palliative care in cancer to date. These patients had lung cancer, not gynecologic cancer, but plans are underway to try to conduct a similar study with gyn cancer patients
This was a trial of stage IV lung cancer patients, randomly chosen to either get
Standard oncology care, oncologist could refer to palliative care specialist if she or he chose
Routine PC from the time of diagnosis, patients would see PC team about once a month
So this was NOT a trial of palliative care vs no palliative care. It was a trial of routine palliative care, from the time of diagnosis, vs usual care
They found that the group that had PC from the time of diagnosis had
-better QOL (this was their primary outcome)
-less depression
-for those who died, less aggressive care at the end of their lives
And the study was not primarily designed to look at survival, but not only did palliative care not shorten patients lives, the patients who received routine palliative care actually lived LONGER than those who received standard care
The trial I just told you about is the most well known among several randomized trials to have shown a benefit of early palliative care integration. Those trials taken together prompted the American Society of Clinical Oncology in 2012 to issue a Provisional Clinical Opinion on the Integration of Palliative Care into Standard Oncology care
Their recommendation was that combined standard oncology care and PC should be considered early in the disease course for any patient with either metastatic cancer and/or high symptom burden
They recently updated this document with latest trials, recommendation remained essentially the same
I just want to quickly mention a few studies specifically in gynecologic cancer that support some of the benefits of palliative care.
This is a study out of Brazil from 2014.
They looked at a group of breast and gyn cancer patients (about half had gyn cancer) who were at the point of discontinuing anti-cancer therapy and they were all moving to purely palliative care. They compared patients who had already seen palliative care prior to reaching the point of discontinuing cancer therapy to those who were having PC introduced for the first time when stopping cancer therapy. So these were two groups essentially capturing the old vs new model of palliative care, where PC was mutually exclusive from vs integrated with, cancer therapy.
The patients who had earlier integration of PC, which they called the integrated care model had
-better QOL
-less depression
-less chemo w/in last 6wks of life
-improved median survival
This is a study we did at Magee, published last year essentially a case series of 95 inpatients with gyn malignancy who had SPC consultation primary for symptom management.
We wanted to look at impact of PC consultation on symptom management. We didn’t have a control group, so we looked at timing of symptom improvement relative to timing of PC consult to try to establish that association.
The primary outcome we looked at was prevalence of moderate to severe symptom intensity.
That improved between PC consult and discharge for pain, anorexia, fatigue & nausea, magnitude on order of 60%
And it improved within one day of PC consult for pain, fatigue & nausea, magnitude on order of 50%
Though we couldn’t prove causation, we did note that the majority of symptom improvement that happened over the hospitalization happened within 24hrs of PC consultation, suggesting an association.
Lowery and colleagues in 2013 looking at CE of early PC integration for platinum resistant ovarian cancer. They used data from the Temel trial to inform the model, which involved PC integration from the time of diagnosis of platinum resistant disease.
Found that early PC associated with cost savings over routine care and even if we assumed no clinical benefit other than QOL improvement, it remained highly CE
In light of the projects I just reviewed, and others,
In 2013, the Society of Gynecologic Oncology, our national society, included palliative care in their choosing wisely list, which is a list intended to highlight either overused or underused services. They advised to delay basic level palliative care for women with advanced or relapsed gyn cancer and, when appropriate, refer to specialty level palliative medicine.
This brings highlights a couple of points
-first being, palliative care is an integral part of the care of women with gynecologic cancers
-second, not all palliative care is provided by palliative care specialists. Which brings us to…
How can you get palliative care?
Before we go there, just to review, the reason we need palliative care is because it improves the quality of care. It improves quality of life, improves symptom burden, at worst does not shorten survival, may even improve survival.
So how can you get it?
How can you get palliative care? You can get palliative care from your oncology team or from palliative care specialists
We use the term primary palliative care to refer to palliative care delivered by providers who are not palliative care specialists – that can be PCP or oncology team, doesn’t have to be physician, can be nurse, NP/PA, SW
Specialty palliative care is palliative care delivered by palliative care specialists – providers specifically trained in palliative care, often involves an interdisciplinary team with MD, NP/PA, RN, SW, chaplain
Specialty palliative care teams may be available in the hospital…
Specialty palliative care can also be delivered at home in the form of home palliative care and hospice care
So we talked in generalities about palliative care definitions and domains, but if you go see a palliative care provider, either in an outpatient clinic or a consultation in the hospital, what actually happens, what do they do?
That varies from patient to patient depending on their needs within the multiple domains of palliative care
But to give you an idea, here’s some data from the landmark trial of palliative care integration in cancer, which was done in the study I told you about earlier with lung cancer patients,
The Center to Advance Palliative Care is a wonderful national organization devoted to palliative care, their website has a number of great features, including…
Why doesn’t every patient with ovarian cancer get palliative care? Let’s talk about some barriers
In terms of availability, there are not enough specialty palliative care providers in the country to provide specialty palliative care to everyone who might benefit from it. There’s a lot of talk in the specialty palliative care community now about how to target the available specialty palliative care capacity to patients who will most benefit from it. I think the specialty palliative care community sometimes jumps too fast to the solution that more palliative care should be primary palliative care, should be provided in cancer care by the oncology team. I think if we’re asking for increased attention to an element of the care of women with ovarian cancer, namely the palliative care element, by the oncology team, we have to increase that team’s capacity, in terms of both education and clinician time or clinician manpower, can’t just assume that an oncology provider who’s already seeing as many patients as they can fit into a day can suddenly start adding good high quality primary palliative care into their visits
Next is poor reimbursement. I didn’t go into this today, partially due to time and partially because I think it’s far secondary to the clinical benefits, but palliative care has been shown to be more cost efficient at the healthcare system level, saving money in terms of shorter ICU stays, less intensive EOL interventions, again all without shortening survival. Despite that, given our current healthcare system model, not well reimbursed in a fee-for-service model, disincentivizing institutions from building these programs. I’m going to get up on my soapbox for one second and just say that I think if palliative care were a drug, that a drug company stood to make a fortune off of, and it had demonstrated benefits like it does, we’d be giving it to every single patient with cancer
Next barrier is lack of provider education
I think our training as gyn oncologists leaves us inadequately prepared for the role of primary palliative care provider
One survey of over 300 gyn oncologists found that only 45% felt that their training had helped them relate to terminally ill patients & families
-in that same study 77% of respondents felt that more training in EOL care would be helpful
Another survey of 103 gyn oncology fellows, they rated the quality & quantity of their palliative care training lower than other common procedural & oncologic issues
-in that survey 89% of fellows said they felt pall care was integral to their training but only 11% reported getting such training
Finally a survey of gyn oncology fellowship directors, only 14% reported having a written curriculum for palliative care; encouragingly almost half said their program had either an elective or required pall care rotation
Then the final barrier I want to mention is that palliative care has a branding problem – we think palliative care is the death squad right?
This cartoon shows grim reaper as new palliative specialist
Earlier I asked you guys this same question – how knowledgeable, if at all, are you about palliative care?
In 2011 the Center to Advance Palliative Care conducted a survey of 800 adults in the US, oversampling people age 65 or over. They found that 70% described themselves as not at all knowledgeable about palliative care.
Palliative care has a branding problem
Pall care also has a branding problem with providers, who have been shown to lack knowledge of palliative care services & benefits and often equate pall care with EOL care
In some ways, I think the branding issue with providers is both a tougher nut to crack, because whereas patients just have lack of knowledge, providers have existing misconceptions. And other research has shown that patients, even those with demonstrated unmet palliative care needs, are unlikely to request a pall care consult, though the vast majority are open to it if their provider suggests it
Some institutions have taken to renaming their palliative care services or divisions supportive care, to try to avoid any negative connotations that patients or providers may have about the phrase palliative care. They did that at MD ACC and found that their referral rates increased after that name chance, so that’s something to consider
The issue of how palliative care is understood, or misunderstood, is so important that in 2014 the Institute of Medicine, in their report Dying in America, concluded that…
When those same people who started out not at all knowledgeable about palliative care were informed about what it is, using the definition we talked about at the beginning including the phrase extra layer of support, they had an overwhelmingly positive reaction
So the public have tended to be uninformed, but when informed, tend to have a very positive view of palliative care
Like any other area of healthcare, progress will require additional research, education (for both patients & providers) and education.
We need education for both patients & providers about palliative care, what it is and isn’t, and normalizing it as part of cancer care
We need research that looks at symptom management, how to best utilize palliative care specialists, how to best elucidate patient & family values and match treatment plans to those values
We need policy that recognizes the contribution that palliative care makes to the care of people with serious illnesses, including ovarian cancer, and incentivizes its use
This room is so rich with passion for the lives of women with ovarian cancer, saving them and I would argue that saving lives is not just about helping women with ovarian cancer live longer, but also helping them live better and I think that improving palliative care integration is one important way to do that.
And it can be as simple as working to normalize palliative care as a routine part of cancer care among your friends and family and the communities that you live and work in
Hopefully you now feel able to define pall care & differentiate it from hospice
Familiar with some of the evidence-based benefits of pall care
Feel able to differentiate between primary palliative care, delivered by PCP or oncology team, and SPC, delivered by specialty palliative care team
For your homework, I want you to at least familiarize yourself with the palliative care resources near you so you know what’s available to you – you can do that by asking your oncologist, by looking on getpalliativecare.org
Here’s a gratuitous picture of our campus and the mountains in the background, I’d be happy to take any questions